Akoya Biosciences, Inc. Quarterly Debt-to-equity in % from Q3 2021 to Q2 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Akoya Biosciences, Inc. quarterly Debt-to-equity history and growth rate from Q3 2021 to Q2 2024.
Akoya Biosciences, Inc. Debt-to-equity for the quarter ending June 30, 2024 was 284 %, a 57.2% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q2 2024	284	+103	+57.2%	Jun 30, 2024
Q1 2024	218	+59.1	+37.1%	Mar 31, 2024
Q4 2023	205	+86.4	+72.8%	Dec 31, 2023
Q3 2023	197	+109	+125%	Sep 30, 2023
Q2 2023	181	+115	+174%	Jun 30, 2023
Q1 2023	159	+107	+206%	Mar 31, 2023
Q4 2022	119	+46.4	+64.3%	Dec 31, 2022
Q3 2022	87.6	-50.4	-36.5%	Sep 30, 2022
Q2 2022	66.1			Jun 30, 2022
Q1 2022	52			Mar 31, 2022
Q4 2021	72.2			Dec 31, 2021
Q3 2021	138			Sep 30, 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.